The Influence of Chemotherapy on Position Sense

Inclusion Criteria

• •General (applies to all participants):
• •At least 18 years of age at the time of signing the informed consent form
• •Voluntary written informed consent of the participant has been obtained prior to any screening procedures
• •Breast cancer surgery-only patient group:
• •The patient is an adult oncological person between 18 and 75 years old who has been treated for cancer
• •The participant has undergone breast cancer surgery but has not received any radiotherapy or chemotherapy treatment (yet).
• •The first session takes place between two and six weeks after breast cancer surgery.
• •The second session takes before any follow-up treatment for breast cancer (radiotherapy or chemotherapy).
• •Chemotherapy group:
• •The patient is an adult oncological person between 18 and 75 years old who has been treated for cancer.
• •The participant has undergone breast cancer surgery but has not received any radiotherapy (yet).
• •Participant has a history of treatment with platinum- or taxane-based chemotherapeutic agents, and this treatment has been terminated no later than 6 weeks before the first session.
• •Healthy control group:
• •No history of cancer or chemotherapy treatment
• •Sex and age-matched to patient sample